XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Revenues    
Operating Expenses        
Research and development 3,452,210 1,551,341 $ 8,910,059 $ 7,742,520
General and administrative 3,117,417 2,293,517 6,014,166 3,982,181
Stock-based compensation – general and administrative 1,020,998 342,962 1,925,602 619,544
Total Operating Expenses 7,590,625 4,187,820 16,849,827 12,344,245
Operating Loss (7,590,625) (4,187,820) (16,849,827) (12,344,245)
Other Income (Expense)        
Interest income 29,571 69,327 63,553 82,811
Interest expense   (3,939)   (7,907)
Total Other Income, Net 29,571 65,388 63,553 74,904
Net Loss $ (7,561,054) $ (4,122,432) $ (16,786,274) $ (12,269,341)
Net Loss Per Share - Basic and Diluted (in Dollars per share) $ (0.05) $ (0.04) $ (0.11) $ (0.16)
Weighted Average Common Shares Outstanding (in Shares)    
Basic and diluted (in Shares) 146,041,852 95,997,427 146,026,847 75,565,121